5,5,8,8-四甲基-5,6,7,8-四氢-2-萘磺酰氯 | 132392-26-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: 5,5,8,8-四甲基-5,6,7,8-四氢-2-萘磺酰氯
• 中文别名: 5,5,8,8-四甲基-5,6,7,8-四氢-2-氯萘
• 英文名称: 5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene-2-sulfonyl chloride
• 英文别名: 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-sulfonyl chloride；2-chlorosulfonyl-5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene；5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenesulfonyl chloride；5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenesulfonyl chloride；5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-sulfonyl chloride
• CAS: 132392-26-8
• 化学式: C₁₄H₁₉ClO₂S
• mdl: MFCD04115384
• 分子量: 286.823
• InChiKey: BEAYCJSJSMOLFG-UHFFFAOYSA-N

物化性质

• 熔点：
  78 °C

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• 储存条件：
  存储条件：2-8°C，密封，干燥

SDS

Name:	5 5 8 8-Tetramethyl-5 6 7 8-tetrahydro-2-naphthalenesulfonyl Material Safety Data Sheet
Synonym:	None Known
CAS:	132392-26-8

Section 1 - Chemical Product MSDS Name:5 5 8 8-Tetramethyl-5 6 7 8-tetrahydro-2-naphthalenesulfonyl Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
132392-26-8	5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro	97+	unlisted

Hazard Symbols: C
Risk Phrases: 14 29 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Reacts violently with water. Contact with water liberates toxic gas.
Causes burns.Water-reactive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Chronic exposure may cause effects similar to those of acute exposure.

---

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid immediately.
Skin:
If water-reactive products are embedded in the skin, no water should be applied. The embedded products should be covered with a light oil. In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give anything by mouth to an unconscious person.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Water Reactive. Material will react with water and may release a flammable and/or toxic gas.
Extinguishing Media:
DO NOT USE WATER! Do NOT get water inside containers. Contact professional fire-fighters immediately. Use dry chemical, dry sand, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Do not expose spill to water. Vacuum or sweep up material and place into a suitable, dry disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not allow water to get into the container because of violent reaction. Minimize dust generation and accumulation. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale.
Use only in a chemical fume hood. Discard contaminated shoes. Keep from contact with moist air and steam.
Storage:
Keep container closed when not in use. Keep away from water.
Corrosives area. Store under an inert atmosphere.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use explosion-proof ventilation equipment. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 132392-26-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: beige
Odor: slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 77.5-79.5 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C14H19SO2Cl
Molecular Weight: 286

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Combines vigorously or explosively with water. Reacts with water to form hydrogen chloride, a toxic and corrosive gas.
Conditions to Avoid:
Dust generation, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Bases, oxidizing agents, water, amines.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of sulfur, carbon dioxide, chlorine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 132392-26-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenesulfonyl chloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: Pseudomonas putida:Fish: Pseudomonas putida:

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, WATER-REACTIVE, N.O.S.
Hazard Class: 8
UN Number: 3096
Packing Group: II
IMO
Shipping Name: CORROSIVE SOLID, WATER-REACTIVE, N.O.S.
Hazard Class: 8
UN Number: 3096
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE SOLID, WATER-REACTIVE, N.O.S.
Hazard Class: 8
UN Number: 3096
Packing group: II

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 14 Reacts violently with water.
R 29 Contact with water liberates toxic gas.
R 34 Causes burns.
Safety Phrases:
S 6 Keep under nitrogen.
S 22 Do not breathe dust.
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 132392-26-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 132392-26-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 132392-26-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5,5,8,8-四甲基-5,6,7,8-四氢-2-萘磺酰氯 在 盐酸 、 锌 作用下， 以 乙醇 为溶剂， 反应 1.0h， 生成 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-thiol
  参考文献：
  名称：

  新型视黄酸受体拮抗剂：含杂环的苯甲酸衍生物的合成与构效关系。

  摘要：

  制备了一系列新的含杂环苯甲酸，并通过体外检测系统使用人类早幼粒细胞白血病（HL-60）细胞评估了其成员对全反式维甲酸的结合亲和力和拮抗作用。结构活性关系表明，N-取代的吡咯或吡唑（1-位）和疏水区（通过环系统连接）对于有效拮抗都是必不可少的。在所评估的化合物中，最佳拮抗作用是通过4- [4,5,7,8,9,10-六氢-7,7,10，-10-四甲基-1-（3-吡啶基甲基）蒽[1,2 -b]吡咯-3-基]苯甲酸（31），4- [4,5,7,8,9,10-六氢-7,7,10,10-四甲基-1-（3-吡啶基甲基）- 5-硫杂蒽[1,2-b]吡咯-3-基]苯甲酸（40）和4- [4,5,7,8,9,10-六氢-7,7,10,10-四甲基- 1-（3-吡啶基甲基）蒽[2，

  DOI：

  10.1021/jm00016a020
• 作为产物：
  描述：

  2,5-二氯-2,5-二甲基己烷 在 氯磺酸 、 aluminum (III) chloride 作用下， 反应 18.0h， 生成 5,5,8,8-四甲基-5,6,7,8-四氢-2-萘磺酰氯
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS FOR INHIBITING CYP26 ENZYMES
  [FR] COMPOSÉS ET MÉTHODES D'INHIBITION D'ENZYMES CYP26

  摘要：

  本文描述的化合物是维甲酸诱导的P450（CYP26）酶的抑制剂，适用于治疗对维甲酸类药物敏感的疾病。某些化合物具有维甲酸活性，对CYP26介导的降解具有抵抗力，并用于治疗对维甲酸类药物敏感的疾病。

  公开号：

  WO2018107289A1

文献信息

• Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation
  作者：Dhulfiqar Ali Abed、Sumi Lee、Xia Wen、Ahmed R. Ali、Vaibhav Mangipudy、Lauren M. Aleksunes、Longqin Hu

  DOI：10.1016/j.bmc.2021.116300

  日期：2021.8

  (Keap1) and nuclear factor erythroid 2-related factor 2 (Nrf2) is recognized as a promising target for the prevention and treatment of oxidative stress-related inflammatory diseases. Herein, a series of novel 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acid analogs (7p-t and 8c) were designed to further explore the structure–activity relationships of the series. Their activities were measured first

  kelch 样 ECH 相关蛋白 1 (Keap1) 和核因子红细胞 2 相关因子 2 (Nrf2) 之间的蛋白质相互作用 (PPI) 被认为是预防和治疗氧化应激相关炎症性疾病的有希望的靶点. 在此，设计了一系列新型 1,4-双（芳基磺酰胺）萘-N，N'-二乙酸类似物（7p-t和8c），以进一步探索该系列的构效关系。首先用荧光偏振 (FP) 测定法测量它们的活性，然后使用更灵敏的时间分辨荧光能量转移 (TR-FRET) 测定法进一步评估更有效的化合物，证明 IC 50值在 7.2 和 31.3 nM 之间。在细胞毒性研究中，萘衍生物对人 HepG2-C8 和小鼠脑 BV-2 小胶质细胞没有显示出明显的毒性。其中，含有含氧稠环的化合物7q可显着刺激细胞 Nrf2 信号通路，包括激活抗氧化反应元件 (ARE) 控制的 Nrf2 靶基因和蛋白质的表达。更重要的是，7q抑制了脂多糖 (LPS) 攻击的
• Heterocycle-containing carbonic acid derivatives
  申请人：Eisai Co., Ltd.

  公开号：US05612356A1

  公开（公告）日：1997-03-18

  A heterocycle-containing carbonic acid derivative represented by the following general formula (I): ##STR1## or a physiologically acceptable salt thereof which exhibits an excellent preventive and therapeutic effect against various diseases, and an intermediate which is useful for the production of the heterocycle-containing carbonic acid derivative.

  以下是通用公式（I）所代表的含杂环的碳酸衍生物，或其生理上可接受的盐，对各种疾病具有出色的预防和治疗效果，以及对生产含杂环的碳酸衍生物有用的中间体。
• MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF
  申请人：Anderson Eric C.

  公开号：US20100029753A1

  公开（公告）日：2010-02-04

  Provided are compounds that are modulators of CCR9 receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of CCR9 receptor activity.

  提供了调节CCR9受体活性的化合物，含有这些化合物的组合物以及使用这些化合物和组合物的方法。在某些实施例中，提供了用于治疗或改善与调节CCR9受体活性相关的疾病的方法。
• Indole Compounds, Method of Preparing Them and Uses Thereof
  申请人：BINET Jean

  公开号：US20080153816A1

  公开（公告）日：2008-06-26

  Indole compounds corresponding to the formula (I): as defined in the claims, pharmaceutically acceptable addition salts of such compounds, pharmaceutical compositions containing such compounds, the process for their preparation, and their use as pharmacologically active substances, especially in the treatment of hypertriglyceridemia, hyperlipidemia, hypercholesterolemia, diabetes, endothelial dysfunction, cardiovascular disease, inflammatory disease and neurodegeneration.

  与公式（I）相对应的吲哚化合物，如权利要求中所定义的，这些化合物的药学上可接受的加盐物，含有这些化合物的药物组合物，其制备方法，以及它们作为药理活性物质的用途，特别是在治疗高三酰甘油血症、高脂血症、高胆固醇血症、糖尿病、内皮功能障碍、心血管疾病、炎症性疾病和神经退行性疾病方面。
• Oxidized diphenylheteroalkanes
  申请人：BASF Aktiengesellschaft

  公开号：US05128479A1

  公开（公告）日：1992-07-07

  Oxidized diphenylheteroalkanes of the formula I ##STR1## where R.sup.1 to R.sup.6 and A have the meanings specified in the description, and the preparation thereof are described. The substances are suitable for controlling diseases and as cosmetic agents.

  氧化的二苯基杂代烷化合物的化学式为I ##STR1## 其中R.sup.1至R.sup.6和A具有描述中指定的含义，以及它们的制备方法被描述。这些物质适用于控制疾病和作为化妆品成分。